US BROKER MOVES: AMAT upgraded at Mizuho; WAL downgraded at JPMorgan
SourceNewsquawk
SectionUS Equities
UPGRADES
- Applied Materials (AMAT) Upgraded to Outperform at Mizuho Securities
- Circle Internet (CRCL) Upgraded to Neutral at Mizuho Securities
- Energy Fuels (EFR CN) Upgraded to Neutral at Roth Capital Partners
- Johnson & Johnson (JNJ) Upgraded to Overweight at Morgan Stanley
- KKR & Co. (KKR) Upgraded to Buy at HSBC; PT USD 144
- Korro Bio, Inc. (KRRO) Upgraded to Outperform at Oppenheimer; PT USD 22
- Korro Bio, Inc. (KRRO) Upgraded to Overweight at Cantor
- Microchip (MCHP) Upgraded to Buy at BofA; PT USD 95
- Nextpower (NXT) Upgraded to Overweight at KeyBanc; PT USD 142
- Texas Instruments (TXN) Upgraded to Neutral at BofA; PT USD 235
- Visa (V) Upgraded to Buy at Rothschild & Co Redburn; PT USD 385
DOWNGRADES
- Array (ARRY) Downgraded to Neutral at Baird; PT USD 11
- BJ's Wholesale (BJ) Downgraded to Hold at Jefferies; PT USD 90
- Brown & Brown (BRO) Downgraded to Neutral at Citi; PT USD 83
- Capital City Bank (CCBG) Downgraded to Market Perform at KBW; PT USD 45
- Martin Marietta (MLM) Downgraded to Hold at Loop Capital; PT USD 690
- Nucor (NUE) Downgraded to Neutral at UBS; PT USD 183
- PayPal (PYPL) Downgraded to Sell at Rothschild & Co Redburn; PT USD 50
- PRA Group (PRAA) Downgraded to Market Perform at Citizens
- Roper (ROP) Downgraded to Hold at Stifel; PT USD 385
- Roper (ROP) Downgraded to Market Perform at Oppenheimer
- Western Alliance (WAL) Downgraded to Neutral at JPMorgan; PT USD 105
INITIATIONS
- Aardvark Therapeutics (AARD) Initiated at New Buy at B Riley; PT USD 32
- Altimmune (ALT) Initiated at New Overweight at Barclays; PT USD 20
- Apellis Pharma (APLS) Initiated at New Equal-Weight at Barclays; PT USD 24
- Ascendis Pharma (ASND) ADRs Initiated at New Overweight at Barclays; PT USD 342
- Bloom Energy (BE) Initiated at New Equal-Weight at Barclays; PT USD 153
- Bridgebio (BBIO) Initiated at New Overweight at Barclays; PT USD 157
- Coinbase (COIN) Initiated at New Neutral at Baird; PT USD 240
- Crescent Biopharma (CBIO) Reinstated Overweight at Piper Sandler
- Dauch Corp. (AXL) American Axle Initiated at New Buy at BWS Financial; PT USD 17
- Entrada Therapeutics (TRDA) Initiated at New Outperform at Oppenheimer; PT USD 21
- FormFactor (FORM) Initiated at New Hold at Freedom Capital; PT USD 64
- Futu Holdings (FUTU) ADRs Reinstated Outperform at CCB Intl; PT USD 250
- GE Vernova (GEV) Initiated at New Buy at China Renaissance; PT USD 966
- Gossamer Bio (GOSS) Initiated at New Overweight at Barclays; PT USD 9
- HeartFlow (HTFL) Initiated at New Overweight at Wells Fargo; PT USD 38
- Insmed (INSM) Initiated at New Overweight at Barclays; PT USD 231
- Madrigal Pharma (MDGL) Initiated at New Overweight at Barclays; PT USD 964
- MBX Biosciences (MBX) Initiated at New Overweight at Barclays
- Nano Nuclear Energy (NNE) Initiated at New Buy at Texas Capital; PT USD 49
- NuScale Power (SMR) Initiated at New Buy at Texas Capital; PT USD 23
- Oklo (OKLO) Initiated at New Buy at Texas Capital; PT USD 138
- Raymond James (RJF) Initiated at New Overweight at Barclays; PT USD 191
- Rush Enterprises (RUSHA) Initiated at New Neutral at UBS; PT USD 70
- Sagimet Biosciences (SGMT) Initiated at New Equal-Weight at Barclays; PT USD 8
- Shattuck Labs (STTK) Initiated at New Overweight at Piper Sandler; PT USD 15
- SiriusXM (SIRI) Initiated at New Neutral at MoffettNathanson LLC; PT USD 21
- Spotify (SPOT) Initiated at New Neutral at MoffettNathanson LLC; PT USD 487
- Tyra Biosciences (TYRA) Initiated at New Overweight at Barclays; PT USD 59
- uniQure (QURE) Initiated at New Equal-Weight at Barclays; PT USD 31
- Warner Music (WMG) Initiated at New Buy at MoffettNathanson LLC; PT USD 38